New TB Vaccine Undergoes Trial

Serum, one of the world’s leading vaccine manufacturers, has signed a contract with Hanover-based Vakzine Projekt Management GmbH and secured the license to manufacture a new TB vaccine. It was originally developed in Germany.

It will be tested in over 2,000 adults in an ambitious trial to be undertaken by Indian Council of Medical Research (ICMR), National Institutes of Health and others.